Sitagliptin Prospective study of Intima media thickness Evaluation

Trial Profile

Sitagliptin Prospective study of Intima media thickness Evaluation

Phase of Trial: Phase II

Latest Information Update: 01 Oct 2017

At a glance

  • Drugs Sitagliptin (Primary)
  • Indications Type 2 diabetes mellitus
  • Focus Biomarker; Pharmacodynamics
  • Acronyms SPIKE
  • Most Recent Events

    • 01 Oct 2017 Results of post-hoc analysis assessing effect of sitagliptin on carotid atherosclerosis, published in the Diabetes Therapy.
    • 01 Jun 2017 Results of prespecified sub-analysis of SPIKE (n=71 sitagliptin group, n=62 conventional group) published in the Diabetes Therapy
    • 03 Feb 2016 Status changed from active, no longer recruiting to completed.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top